sdz mrl 953 has been researched along with Respiratory Distress Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, N; Ishizaka, A; Nakamura, H; Sakamaki, F; Sayama, K; Soejima, K; Tasaka, S; Terashima, T; Urano, T; Waki, Y | 1 |
1 other study(ies) available for sdz mrl 953 and Respiratory Distress Syndrome
Article | Year |
---|---|
Effects of pretreatment with SDZ MRL 953, a novel immunostimulatory lipid A analog, on endotoxin-induced acute lung injury in guinea pigs.
Topics: Adjuvants, Immunologic; Albumins; Animals; Bronchoalveolar Lavage Fluid; Endotoxins; Female; Guinea Pigs; Hemodynamics; Leukocyte Count; Lipid A; Lipopolysaccharides; Lung; Neutrophils; Respiratory Distress Syndrome; Sepsis; Survival Rate; Tumor Necrosis Factor-alpha; Water | 1995 |